Clinical Trial Update: Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI [Phase 4]

View source ↗

Summary

A Phase 4 trial of liraglutide explored changes in brain activity related to appetite using fMRI in people with obesity and diabetes, identifying CNS targets. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Diabetes, Effects of Liraglutide Administration on Brain Activity | Phase 4 | Status: COMPLETED | Results posted: 2017-05-31